Aspiriant LLC’s Invesco S&P MidCap 400 Pure Value ETF RFV Stock Holding History

Aspiriant LLC’s Portfolio RFV Stock Details RFV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,665	Closed	-$534K	–	292
2023 Q1	$534K	Buy	+5,665	New	+$561K	0.03%	171

Other funds holding RFV

FIS

Fischer Investment Strategies Westlake Village, California $171M AUM 24.03% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SWA

Stratos Wealth Advisors Beachwood, Ohio $1.63B AUM 16.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

CPC

Consolidated Planning Corp Atlanta, Georgia $617M AUM 21.61% 1-Year Est. Return

Aspiriant LLC's RFV Position: Q2 2023 in Review

Aspiriant LLC sold out of Invesco S&P MidCap 400 Pure Value ETF (RFV) in Q2 2023, closing a stake of 5,665 shares — an estimated $534K sold.

Aspiriant LLC first reported a position in RFV in Q1 2023 and held it in 1 quarter. The position peaked at $534K in Q1 2023. 52 funds tracked by Wall St. Rank hold RFV as of Q2 2023.

Aspiriant LLC reported no remaining Invesco S&P MidCap 400 Pure Value ETF position as of Q2 2023 after selling out during the quarter.
Aspiriant LLC sold 5,665 Invesco S&P MidCap 400 Pure Value ETF shares in Q2 2023, an estimated $534K.
Aspiriant LLC first reported a position in Invesco S&P MidCap 400 Pure Value ETF in Q1 2023 and held it in 1 quarter.
Aspiriant LLC's Invesco S&P MidCap 400 Pure Value ETF position peaked at $534K in Q1 2023.
52 funds tracked by Wall St. Rank held Invesco S&P MidCap 400 Pure Value ETF as of Q2 2023.

Based on Aspiriant LLC's 13F filing for Q2 2023, filed 19 Jul 2023.